Protagonist Therapeutics Inc (PTGX)
Cash & Short-Term Investments
$782.58M
Quarterly · Period ending: · USD
PTGX Cash & Short-Term Investments
Latest reported$782.58Mperiod ending
Latest reported$782.58Mperiod ending
PTGX Quarterly Cash & Short-Term Investments ($9.32M → $782.58M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
PTGX cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 782,576,000 | |
| 547,786,000 | |
| 567,364,000 | |
| 576,117,000 | |
| 570,465,000 | |
| 574,360,000 | |
| 418,913,000 | |
| 468,721,000 | |
| 563,997,000 | |
| 322,635,000 | |
| 341,617,000 | |
| 320,751,000 | |
| 313,401,000 | |
| 230,759,000 | |
| 237,355,000 | |
| 267,437,000 | |
| 291,890,000 | |
| 305,289,000 | |
| 326,900,000 | |
| 314,301,000 | |
| 354,280,000 | |
| 273,476,000 | |
| 305,809,000 | |
| 193,974,000 | |
| 208,665,000 | |
| 117,513,000 | |
| 133,017,000 | |
| 137,692,000 | |
| 126,101,000 | |
| 112,546,000 | |
| 128,853,000 | |
| 138,517,000 | |
| 125,167,000 | |
| 134,960,000 | |
| 144,001,000 | |
| 93,586,000 | |
| 64,492,000 | |
| 63,248,000 | |
| 77,599,000 | |
| 98,523,000 | |
| 20,176,000 | |
| 29,022,000 | |
| 11,923,000 | |
| 9,324,000 |